OBJECTIVES: Although pediatric obstructive sleep apnea (OSA) is estimated to affect 2-3% of the general population, its prevalence in sickle cell disease (SCD) is much higher, with research suggesting a prevalence rate of upwards of 40%. Despite the similar underlying pathophysiological mechanisms of neurocognitive effects in pediatric OSA and SCD, there is a scarcity of information on how these two conditions interact. The aim of this study was to better understand the contribution of sleep apnea to neurocognitive deficits in children diagnosed with SCD.
METHOD: This study assessed cognitive function in 26 children with comorbid SCD and OSA, 39 matched comparisons with SCD only, and 59 matched comparisons in children without a chronic health condition.
RESULTS: There were significant differences on measures of processing speed and reading decoding, with children without a chronic health condition scoring better than both chronic health condition groups. Additionally, the no chronic health condition group performed better on a test of quantitative knowledge and reasoning and a test of visual-spatial construction than the SCD-only group. Contrary to our hypotheses, there were no between-group differences suggesting an additive impact of OSA on cognition. Exploratory analyses revealed associations within the group that had OSA showing that more severe OSA correlated with lower performance on measures of processing speed and quantitative knowledge/reasoning.
CONCLUSIONS: Children with comorbid OSA and SCD do not present with greater deficits in cognitive functioning than children with SCD alone. However, severe OSA may confer additional risk for neurocognitive impairments.
J Int Neuropsychol Soc. 2006 Jan;12(1):24-33
[PMID:
16433941]
J Pediatr Psychol. 2010 Sep;35(8):892-904
[PMID:
20026570]
Front Neurol. 2012 May 29;3:87
[PMID:
22661967]
Adv Nurse Pract. 2000 Oct;8(10):57-9
[PMID:
11761539]
Am J Hematol. 1999 Apr;60(4):268-72
[PMID:
10203099]
Pediatrics. 2010 Nov;126(5):e1161-7
[PMID:
20956420]
Pediatrics. 2014 Aug;134(2):273-81
[PMID:
25022740]
Eur Respir J. 2005 Feb;25(2):336-42
[PMID:
15684300]
Dev Sci. 2006 Jul;9(4):388-99
[PMID:
16764612]
Pediatr Blood Cancer. 2011 May;56(5):783-8
[PMID:
21370411]
Ment Retard Dev Disabil Res Rev. 2006;12(3):200-7
[PMID:
17061284]
J Int Neuropsychol Soc. 2010 Mar;16(2):326-34
[PMID:
20128934]
J Pediatr. 2004 Oct;145(4):458-64
[PMID:
15480367]
Sleep Breath. 2018 Sep;22(3):797-804
[PMID:
29450676]
Lancet. 2001 May 26;357(9269):1656-9
[PMID:
11425370]
Br J Haematol. 2013 Nov;163(3):373-6
[PMID:
23889205]
J Pediatr Psychol. 2008 Nov-Dec;33(10):1153-62
[PMID:
18400838]
J Int Neuropsychol Soc. 2004 Nov;10(7):962-75
[PMID:
15803560]
Expert Rev Respir Med. 2011 Jun;5(3):425-40
[PMID:
21702663]
J Pediatr Psychol. 2002 Dec;27(8):739-48
[PMID:
12403864]
J Clin Exp Neuropsychol. 2004 Feb;26(1):43-54
[PMID:
14972693]
Br J Haematol. 2005 Aug;130(3):437-44
[PMID:
16042695]
Sleep Med Rev. 2009 Apr;13(2):123-31
[PMID:
19059794]
Pediatrics. 2001 Jun;107(6):1394-9
[PMID:
11389263]
J Int Neuropsychol Soc. 2012 Jan;18(1):168-73
[PMID:
22114954]
Child Neuropsychol. 2007 Mar;13(2):120-31
[PMID:
17364569]
Ann Neurol. 1988 Jun;23(6):614-6
[PMID:
3408243]
Sleep Med. 2016 Jun;22:47-49
[PMID:
27544835]
Sleep. 2003 Dec 15;26(8):999-1005
[PMID:
14746381]
J Craniofac Surg. 2004 Jul;15(4):670-4
[PMID:
15213550]
Ann Neurol. 2006 Apr;59(4):662-72
[PMID:
16450382]
Blood. 1999 Jan 1;93(1):71-9
[PMID:
9864148]
J Child Neurol. 2005 Feb;20(2):102-7
[PMID:
15794173]
Dev Neuropsychol. 2009;34(1):122-36
[PMID:
19142770]
Pediatrics. 2003 Oct;112(4):870-7
[PMID:
14523179]
Am J Prev Med. 2010 Apr;38(4 Suppl):S512-21
[PMID:
20331952]
Neurology. 2001 Apr 24;56(8):1109-11
[PMID:
11320190]
